Literature DB >> 30069181

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018.

Cornelia Liedtke1, Christian Jackisch2, Marc Thill3, Christoph Thomssen4, Volkmar Müller5, Wolfgang Janni6.   

Abstract

Entities:  

Keywords:  Arbeitsgemeinschaft Gynäkologische Onkologie (AGO); Early breast cancer; Local therapy; Systemic therapy; Treatment recommendations

Year:  2018        PMID： 30069181      PMCID： PMC6062659          DOI： 10.1159/000489329

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  9 in total

1.  Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting.

Authors:  Thorsten Kühn; Jean-Marc Classe; Oreste David Gentilini; Corrado Tinterri; Florentia Peintinger; Jana de Boniface
Journal:  Breast Care (Basel)       Date:  2018-09-26       Impact factor: 2.860

2.  Axillary Surgery in Breast Cancer Patients Treated with Breast-Conserving Surgery at German Breast Cancer Centers Within the Last 14 Years - Comparison of a University Center and a Community Hospital.

Authors:  Amelie de Gregorio; Peter Widschwendter; Susanne Albrecht; Nikolaus de Gregorio; Thomas W P Friedl; Jens Huober; Wolfgang Janni; Florian K Ebner
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-11-26       Impact factor: 2.915

3.  Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.

Authors:  Xiaoyu Li; Shujun Xia; Wei Zhou; Ri Ji; Weiwei Zhan
Journal:  Int J Nanomedicine       Date:  2019-04-05

4.  Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer.

Authors:  Florian Schütz; Peter A Fasching; Manfred Welslau; Andreas D Hartkopf; Achim Wöckel; Michael P Lux; Wolfgang Janni; Johannes Ettl; Diana Lüftner; Erik Belleville; Hans-Christian Kolberg; Friedrich Overkamp; Florin-Andrei Taran; Sara Y Brucker; Markus Wallwiener; Hans Tesch; Tanja N Fehm; Andreas Schneeweiss; Volkmar Müller
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-10-22       Impact factor: 2.915

5.  A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist.

Authors:  Hanqiong Zhou; Haiyang Chen; Cheng Cheng; Xuan Wu; Yanfang Ma; Jing Han; Ding Li; Geok Hoon Lim; Warren M Rozen; Naohiro Ishii; Pankaj G Roy; Qiming Wang
Journal:  Ann Transl Med       Date:  2021-07

6.  Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results.

Authors:  Aurelia Noske; Sophie-Isabelle Anders; Johannes Ettl; Alexander Hapfelmeier; Katja Steiger; Katja Specht; Wilko Weichert; Marion Kiechle; Evelyn Klein
Journal:  Breast       Date:  2019-11-12       Impact factor: 4.380

7.  Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer.

Authors:  Manfred Welslau; Andreas D Hartkopf; Volkmar Müller; Achim Wöckel; Michael P Lux; Wolfgang Janni; Johannes Ettl; Diana Lüftner; Erik Belleville; Florian Schütz; Peter A Fasching; Hans-Christian Kolberg; Naiba Nabieva; Friedrich Overkamp; Florin-Andrei Taran; Sara Y Brucker; Markus Wallwiener; Hans Tesch; Andreas Schneeweiss; Tanja N Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-10-22       Impact factor: 2.915

Review 8.  Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3.

Authors:  Diana Lüftner; Gary H Lyman; João Gonçalves; Xavier Pivot; Minji Seo
Journal:  Target Oncol       Date:  2020-08       Impact factor: 4.493

9.  Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.

Authors:  Signe Borgquist; Lisa Rydén; Ida Skarping; Daniel Förnvik; Sophia Zackrisson
Journal:  Breast Cancer Res Treat       Date:  2021-06-12       Impact factor: 4.872
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.